Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: MRK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on MRK, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 1,097,509 MRK shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,097,509 shares
    Change vs previous 13F -343,757 shares

    2.58% of the 13F portfolio, value $141,029,906.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,441,266 shares
    Change vs previous 13F -134,545 shares

    3.34% of the 13F portfolio, value $173,369,887.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,575,811 shares
    Change vs previous 13F -95,741 shares

    3.48% of the 13F portfolio, value $165,882,303.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,671,552 shares
    Change vs previous 13F -142,708 shares

    3.15% of the 13F portfolio, value $140,303,944.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,814,260 shares
    Change vs previous 13F -153,710 shares

    4.45% of the 13F portfolio, value $143,627,779.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,967,970 shares
    Change vs previous 13F +119,339 shares

    5.53% of the 13F portfolio, value $176,659,161.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,848,631 shares
    Change vs previous 13F +272,815 shares

    6.39% of the 13F portfolio, value $183,916,663.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,575,816 shares
    Change vs previous 13F not available

    6.2% of the 13F portfolio, value $178,962,562.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).